The incorporation of parental genotypic information allowed for determination of parental origin; all cases in this study were diandric triploidy. Clinically, selleck kinase inhibitor these cases would likely present as partial molar pregnancies, which would be at risk for gestational trophoblastic neoplasia and choriocarcinoma, a malignant trophoblastic cancer.23, 24 and 25 Digynic triploidies should also be detectable with this SNP-based method. However, these pregnancies

present with very small, nonmolar placentas,26 which is correlated with decreased fetal cfDNA fractions and complicates detection using NIPT.10 However, previous studies showed that an “extremely low fetal fraction” per se increased the risk of fetal chromosomal aneuploidy, including digynic triploidy.10 and 12 The prevalence of twin pregnancies is approximately 1 in 30 births,27 and 28 with vanishing twins occurring in approximately 30% of early diagnosed twin pregnancies.29, 30, 31, 32 and 33 This is substantially higher than for triploid pregnancies, which occur in approximately 1 in 2000 pregnancies at 12 weeks of gestation, when many women undergo NIPT.34 and 35 BMS-907351 clinical trial Thus, the substantially greater possibility of a vanishing twin pregnancy (or unrecognized multiple gestation) should not be overlooked upon a screen-positive

result. The increased incidence of twinning in developed countries, a reflection of the progressive rise in the average maternal age at the time of conception36 and 37 and increasing utilization of assisted reproductive technology (ART),27 has important clinical implications for prenatal screening. Specifically, twinning rates are higher in women using ART, so the proportion of vanishing twin pregnancies is also likely higher. Indeed,

9% of conceptions using intracytoplasmic sperm injection resulted in vanishing twin pregnancies.38 However, it is unclear how many women in this cohort used ART; the number of cases found to involve a vanishing twin was 0.18% (additional fetal haplotypes were identified in 0.42% of the 30,795 cases, and of those cases with clinical follow-up, 42.7% were vanishing twin why pregnancies, for 0.42% × 42.7%). It may be reasonable to assume that the rate of aneuploidy among vanished twins is similar to that found in analysis of POC samples, which was reported to be about 60%.39 and 40 This implies that approximately 0.11% of NIPT cases involve a chromosomally abnormal vanishing twin. As this is the same order of magnitude as NIPT false-positive rates, it is not surprising that vanishing twins have been found to be responsible for a significant proportion of false positives in some studies14 and 20 using NIPT methods that cannot detect vanished twins. Determining a more precise correlation between vanishing twins and aneuploidy as well as fetal fraction is an important area for ongoing research, but is beyond the scope of this present study.